TearLab Corp. is a health care company in developing diagnostic devices for eye disease. TearLab reported the following data(in thousands) for three recent years. For Years Ended December 31 Cash and cash equivalents- Year3 - $13,838 Year2- $16,338 Year1- $37,778 Net cash flows from operations- Year3-(23,703) Year2- (18,172) Year1- (13,234) Question1 (a) Determine the monthly cash expenses for Year3, Year2, and Year1.Round to one decimal place. (b) Determine the ratio of cash to monthly cash expenses as of December31 for Year 3, Year 2, and Year 1. Round to one decimal place. (c) Based on question 1 (a) and (b) , comment on TearLab's ratio of cash to monthly operating exoenses for Year 3, Year 2, and Year 1.